CatalystPit

WVEWave Life Sciences, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $3.70 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$729.08M
RECENT INSIDER TRADES
  • 2026-10-07 · TAKANASHI KEN (Director) · OTHER
  • 2026-10-07 · CORRIGAN MARK (Director) · OTHER
  • 2026-10-07 · Verdine Gregory L. (Director) · OTHER
  • 2026-10-07 · Tan Aik Na (Director) · OTHER
  • 2026-10-07 · Rawcliffe Adrian (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders77
Shares held136,205,369
Value$825.03M
Percent of shares outstanding69.12%
As of quarter end2026-06-30
RECENT NEWS
  • Wave Life jumps as FDA backs registrational plans for AATD therapy
  • Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD
  • Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development
  • Wave Life Sciences starts Phase 2a trial of WVE-007 with tirzepatide for obesity
  • JPMorgan resumes Wave Life Sciences stock rating at Neutral
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS